U.S. Markets closed
  • Crude Oil

    70.51
    -0.05 (-0.07%)
     
  • Gold

    1,778.80
    +0.60 (+0.03%)
     
  • Silver

    22.53
    -0.04 (-0.17%)
     
  • EUR/USD

    1.1723
    -0.0007 (-0.0586%)
     
  • 10-Yr Bond

    1.3240
    +0.0150 (+1.15%)
     
  • Vix

    24.36
    -1.35 (-5.25%)
     
  • GBP/USD

    1.3650
    -0.0014 (-0.1010%)
     
  • USD/JPY

    109.4690
    +0.2490 (+0.2280%)
     
  • BTC-USD

    44,590.88
    -3,435.44 (-7.15%)
     
  • CMC Crypto 200

    1,045.43
    -18.42 (-1.73%)
     
  • FTSE 100

    6,980.98
    +77.07 (+1.12%)
     
  • Nikkei 225

    29,665.42
    -174.29 (-0.58%)
     

Why BeyondSpring Stock Skyrocketed Today

·1 min read
Why BeyondSpring Stock Skyrocketed Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Shares of BeyondSpring (NASDAQ: BYSI) soared on Wednesday after the pharmaceutical company released promising clinical trial results for its investigational lung cancer treatment. A phase 3 trial of BeyondSpring's plinabulin treatment in combination with chemotherapy medication docetaxel to treat second and third line non-small cell lung cancer (NSCLC) reached its primary endpoint of statistically significant improvement in overall survival versus docetaxel alone. The combination treatment study also met its secondary endpoints, including significantly improving overall response rate (the proportion of patients whose tumor is reduced by a drug), progression-free survival rate, and 24- and 36-month overall survival rates.